Patients treated with NBT of ulcerative colitis showed lower expression of CD44 in CD44+CD14+ lymphocytes, whereas for the patients treated with biological therapy, there was no difference in comparison to the healthy control group. This evidence concerns the gene CD44 and ulcerative colitis.